[Expert testimony in post-traumatic stress disorder with pain as the main symptom].

Schmerz

Psychosomatische Fachklinik Kinzigtal, Wolfsweg 12, 77723, Gengenbach, Deutschland,

Published: August 2014

Post-traumatic stress disorder (PTSD) is one of the most relevant disorders of patients with chronic pain, but is often underdiagnosed. This also applies to expert testimony. Further complicating the assessment are the different definitions of PTSD in ICD-10 and DSM-IV; the new DSM-5 has added a further definition. The present review aims to provide guidance for making a valid diagnosis. This forms the basis for a differentiated expert testimony in the different fields of law (e.g., criminal law, statutory or private accident insurance or social security benefits), in which different requirements must be taken into consideration by the expert. The recognition of malingering is described at length, which plays a major role in PTSD expert testimony in all fields of law.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00482-014-1416-4DOI Listing

Publication Analysis

Top Keywords

expert testimony
12
post-traumatic stress
8
stress disorder
8
testimony fields
8
fields law
8
[expert testimony
4
testimony post-traumatic
4
disorder pain
4
pain main
4
main symptom]
4

Similar Publications

Introduction: Preventing depression among nurses is a critical issue from the perspective of occupational welfare, but associations between depressive symptoms in nurses and stress-coping strategies remain unclear.

Methods: In the present study, an epidemiological study was conducted based on a cross-sectional questionnaire survey. Data obtained from 2,534 female nurses working at three general hospitals in Tokyo, Japan, were analyzed.

View Article and Find Full Text PDF

Objectives: The objective is to compare the learning curves between two pioneer and three second-generation surgeons for RAPN in terms of WIT, CD and positive surgical margins.

Materials And Methods: The charts of consecutive RAPNs of three centres were reviewed from the UroCCR prospective database. The experience was assessed by a regression model for each group.

View Article and Find Full Text PDF

Tarlatamab is a bispecific T-cell engager immunotherapy targeting delta-like ligand 3 (DLL3) and the cluster of differentiation 3 (CD3) molecule. In the phase 2 DeLLphi-301 trial of tarlatamab for patients with previously treated small cell lung cancer, tarlatamab 10 mg every 2 weeks achieved durable responses and encouraging survival outcomes. Analyses of updated safety data from the DeLLphi-301 trial demonstrated that the most common treatment-emergent adverse events were cytokine release syndrome (53%), pyrexia (38%), decreased appetite (36%), dysgeusia (32%), and an emia (30%).

View Article and Find Full Text PDF

Background: "Before medically advised" (BMA) discharges are rising among hospitalized people with opioid use disorder (OUD) and associated with worse outcomes. However, little is known about BMA discharge among the growing share of U.S.

View Article and Find Full Text PDF

Calcium (Ca) is necessary for bone health and metabolic functions in poultry, however, the extent to which it can be utilized varies among feed ingredients. The goal of this study was to determine the apparent ileal digestibility (AID) and standardized ileal digestibility (SID) of calcium in wheat and soybean meal (SBM) in young quail chicks using a direct method. Three dietary treatments were used in the experiment: a calcium-free basal diet to determine endogenous calcium losses, and two diets with either wheat or SBM as the primary calcium sources.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!